N-acetylserotonin (NAS), the immediate precursor of melatonin, the pineal gland indole, is regulated in a circadian rhythm. NAS swiftly activates TrkB in a circadian manner and exhibits antidepressant effect in a TrkB-dependent manner. Here we show that NAS regulates an early event of neurogenesis by increasing neuronal progenitor cell (NPC) proliferation. Subchronic and chronic NAS administration induces NPC proliferation in adult mice. Chronic NAS treatment triggers TrkB receptor activation and its downstream signaling in NPCs. Blockade of TrkB abolishes NAS-elicited neurogenesis in TrkBF616A knockin mice, suggesting that TrkB activation is essential for the effect of NAS-induced NPC proliferation. Moreover, NAS induces NPC proliferation in both active and sleeping phases of the mice. Strikingly, NAS significantly enhances NPC proliferation in sleep-deprived mice. Thus, our finding demonstrates a unique function of NAS in promoting robust NPC proliferation, which may contribute to hippocampal plasticity during sleeping period.
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sleep deprivation | brain-derived neurotrophic factor S erotonin N-acetyltransferase (arylalkylamine nacetyltransferase, AANAT) is an enzyme that catalyzes the metabolism of the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) into N-acetylserotonin (NAS). AANAT mRNA is predominantly expressed in the pineal gland and retina. In the pineal gland, NAS is an intermediate in the synthesis of melatonin from serotonin. Accumulating evidence suggests that NAS acts as a mediator of the antidepressant action of drugs, and chronic but not acute treatment of rats with the antidepressant fluoxetine increases the content of AANAT mRNA in the rat hippocampus (1) . Consistent with this observation, it has been reported that C3H mice that possess wild-type (WT) AANAT display shorter duration of immobility than C57 BL6 mice that have a mutation in the AANAT gene and are considered as AANAT-deficient and consequently NAS-and melatonin-deficient animals (2, 3) . Moreover, tail suspension tests show that administration (i.p.) of NAS reveals antidepressant effect (4, 5) . Recently, we showed that NAS directly activates TrkB in a circadian manner and exhibits antidepressant effect in a TrkB-dependent way. NAS rapidly activates TrkB, but not TrkA or TrkC, in a neurotrophinand MT3 receptor-independent manner. Administration of NAS activates TrkB in brain-derived neurotrophic factor (BDNF) knockout mice. Hence, our findings support the hypothesis that NAS is more than a melatonin precursor, and that it can potently activate TrkB receptor (6) . Antidepressant drugs induce hippocampal cell proliferation and neurogenesis in adult rats (7) , and blocking neurogenesis abolishes the therapeutic actions of antidepressant drugs (8) . However, it remains unknown whether NAS also provokes neuronal progenitor cell (NPC) proliferation in hippocampus as it does in other antidepressants.
NPC proliferation is an early event of neurogenesis, a process by which new neurons are continuously generated and incorporated into the nervous system. New neurons are continually generated in the subgranular zone of the dentate gyrus and in the subventricular zone of the lateral ventricles of the adult brain. These neurons proliferate, differentiate, and become integrated into neuronal circuits. Neurogenesis occurs throughout adulthood in the dentate gyrus of the hippocampus in many mammals including mice, rats, monkeys, and humans (9, 10) . It had been shown that aging and stress can suppress neurogenesis but enriched environmental conditions, voluntary exercise such as running, as well as antidepressants can positively modulate hippocampal neurogenesis (11) (12) (13) (14) . Mounting evidence suggests that sleep may contribute to hippocampal functions by promoting neurogenesis. Prolonged restriction or disruption of sleep leads to a major decrease in hippocampal cell proliferation, cell survival, and neurogenesis. Although short sleep deprivation may not affect the basal rate of cell proliferation, even mild sleep restriction may interfere with the increase in neurogenesis that normally occurs with hippocampus-dependent learning (15, 16) .
BDNF, one of the major neurotrophins, regulates not only neuronal survival and neuronal plasticity but also neurogenesis. BDNF exerts its neurotrophic function through its receptor, TrkB. The phosphorylation of TrkB results in the activation of three major downstream signaling cascades, including mitogenactivated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K), and phospholipase C-γ1. By directly ablating the TrkB receptor in dentate gyrus NPCs, an unambiguous, cell-autonomous requirement for TrkB in maintaining proliferation and neurogenesis in hippocampus has been established. Deletion of TrkB abolishes the proliferative and neurogenic effects of chronic antidepressant treatments and voluntary exercise (17) . This is consistent with earlier observations that both antidepressants and running induce significant increases in BDNF level (18, 19) . The inability of TrkB null NPCs to respond to antidepressants and running was most likely due to the lack of sensitivity to BDNF. In the current study, we report that NAS but not melatonin plays an essential role in hippocampal NPC proliferation. It triggers NPC proliferation in both active and sleeping phases of the mice. Notably, it significantly prevents the loss of NPC proliferation in sleep-deprived mice through activating the TrkB receptor. Hence, this finding establishes a unique function of NAS in promoting NPC proliferation and deciphers NAS's role in sleepmediated hippocampal plasticity.
Results

NAS but Not Melatonin Induces NPC Proliferation and TrkB Activation
in Hippocampal Dentate Gyrus. NAS but not melatonin mimics BDNF's functions and triggers TrkB phosphorylation (6) . Deletion of TrkB impairs NPC proliferation and neurogenesis in hippocampus (17) . To investigate the effect of NAS on hippocampal cell proliferation, we treated C57BL/6J mice with vehicle, 20 mg/kg NAS, and 8 mg/kg melatonin daily at 19:00 h via i.p. injection for 3 wk and examined hippocampal cell proliferation by monitoring BrdU incorporation in dentate gyrus (Fig. 1A) . The doses of NAS and melatonin had been used in previous studies (6, 20, 21) BrdU + cells were used as a marker for cell proliferation. Quantitative analysis showed that 3 wk of NAS treatment increased cell proliferation by ∼31% (vehicle: 1,068 ± 146; NAS: 1,342 ± 161; melatonin: 1,088 ± 100), whereas melatonin had no effect ( Fig. 1 B and C) . This result indicates a unique function of NAS, which may act as an endogenous NPC proliferation inducer. To investigate whether NAS activates TrkB receptor in NPCs, we analyzed the distribution of phospho-TrkB in NPCs by coimmunostaining of nestin (an NPC marker) and p-706 TrkB antibodies. The number of nestin immunoreactive cells and both nestin and p-706 TrkB + cells were increased ∼1.3-fold after NAS treatment (vehicle: 1,003 ± 95; NAS: 1,404 ± 182; melatonin: 1,110 ± 105); however, melatonin had no effect compared with vehicle control (Fig. 1 D and E ). These results demonstrate that NAS can trigger TrkB phosphorylation in hippocampal NPCs, suggesting that NAS may regulate NPC proliferation by directly activating TrkB receptor in NPCs.
Chronic NAS Treatment Activates TrkB and Its Downstream Signaling in the Hippocampus. NAS swiftly activates TrkB and its downstream signaling cascades including Akt and MAPK in primary neurons (6) . We also showed that NAS increased TrkB activation in the hippocampus and retina in BDNF conditional knockout mice starting from 30 min. To confirm the effect of NAS on TrkB activation, we administrated 20 mg/kg NAS to mature male C57BL6J mice via i.p. injection. The hippocampal tissues were prepared at different time points. An immunoblotting experiment showed that TrkB activation increased at 1 h and peaked at 2 h following NAS treatment. The signal faded away from 4 to 8 h ( Fig. 2A ). This result confirms the effect of NAS on TrkB activation in the hippocampus. To investigate whether chronic NAS treatment mediates TrkB phosphorylation, we injected the mice with NAS daily for 3 wk. The results from ELISA showed a tendency that NAS activated p-TrkB 817 in the hippocampus (Fig.  2B ). Immunoblotting from p-TrkB 706 antibody also displayed a similar TrkB activation pattern by NAS ( Fig. 2 C and D) . To test whether MAPK, a downstream signaling effector of TrkB, is also activated by NAS treatment, we conducted immunoblotting analysis with p-Erk 1/2 and total Erk 1/2 antibodies. Quantitative analysis of signals from p-MAPK/total MAPK also showed that NAS activated MAPK over twofold, correlating with the TrkB phosphorylation pattern ( Fig. 2 E and F) . Hence, chronic NAS treatment activates TrkB and its downstream signaling in hippocampus.
Blockade of TrkB Receptor Inhibits NAS-Induced Cell Proliferation in the Dentate Gyrus. TrkB plays an essential role in regulating neuronal survival, neuronal plasticity, and neurogenesis. However, whether NAS-induced hippocampal cell proliferation is dependent on TrkB receptor is not yet answered. To address this question, we injected NAS daily into TrkB F616A knockin mice for 3 wk (Fig. 3A) . It has been shown before that TrkB F616A can be selectively blocked by water-soluble kinase inhibitor PP1 derivative, 1NMPP1. This compound blocks the kinase domain of the mutated TrkB receptor but not wild-type Trk receptors, leading to a TrkB-null phenotype (22) . We fed the animals with 25 μM 1NMPP1 in drinking water before the first NAS administration to inhibit the mutated TrkB F616A. 1NMPP1 and NAS treatment regimes were continued up to 3 wk of the whole period of the experiment. In the WT control group, NAS treatment significantly increased BrdU + cells compared with vehicle control. As expected, blockade of TrkB by 1NMPP1 abolished the effect of NASinduced cell proliferation (Fig. 3B) . Immunohistochemical staining and quantitative analysis revealed that NAS potently activated TrkB and its downstream, MAPK, in NPCs as well, and both of them were notably reduced by 1NMPP1 pretreatment (Fig. 3 C-F), indicating that TrkB receptor is indispensable for NASprovoked MAPK activation. Thus, this result supports that TrkB signaling cascade activation by NAS is required for promoting NPC proliferation.
NAS Regulates Hippocampal Cell Proliferation During Sleeping and
Active Phase. In pineal gland, NAS synthesis is under control of the circadian clock with levels that are high during the dark phase and low in the light phase. Because NAS levels are high the dark phase in human, we hypothesized that NAS may reg- ulate hippocampal cell proliferation in the dark phase. To address this possibility, we used the wild-type C3Hf( +/+ ) mice, which express NAS in the nighttime as in human. We injected the mice at an early light phase, 7:00 AM (zeitgeber time 0, ZT0), and early of the dark phase, 7:00 PM (ZT12) (Fig. 4A) . Subchronic NAS administration for 4 d did not significantly increase BrdU + cells in either light or dark phase (sleeping or active phase, respectively) (Fig. 4B) . However, an up-regulation tendency in cell proliferation by NAS was observed in C3Hf(+) mice. Because C3Hf( +/+ ) mice have endogenous NAS, which may conceal the effect of exogenous NAS, we used C57BL/6J mice that express a mutant inactive AANAT and express negligible levels of NAS in the nighttime to investigate the effect of NAS on neurogenesis. We hypothesized that an increase of NAS during sleeping phase, as in human, may trigger hippocampal cell proliferation during sleep. C57BL/6J mice were injected with NAS daily for 4 d. NAS treatment in an early sleeping phase (7:00 AM) significantly increased BrdU + cells. NAS administration every 12 h at both 7:00 AM and 7:00 PM further increased BrdU + cells (Fig. 4C) . These results emphasize the effect of NAS on hippocampal cell proliferation. We did not include the subchronic 7:00 PM injection in C57BL/6 mice, because it has been shown that chronic 7:00 PM injection of NAS induces neurogenesis (Fig. 1B) . Hence, these results support that exogenous NAS can enhance hippocampal cell proliferation in both active and sleeping phases of the animals.
NAS Protects Sleep Deprivation-Suppressed NPC Proliferation. It has been reported that NPC proliferation and neurogenesis can be suppressed by several lifestyle manipulations, including sleep deprivation (15, 23) . To further explore whether NAS exerts any protective effect during sleep deprivation, we subjected C3Hf( +/+ ) mice to a well-established sleep deprivation protocol (24) and injected mice with either vehicle or NAS every 12 h until the experiment ended after 96 h (Fig. 5A) (Fig. 5B) . Then, we performed a similar experiment with C57BL/6J mice. As shown in Fig. 5 , sleep deprivation evidently decreased BrdU + cells and NAS treatment prevented the decrease in cell proliferation. The BrdU incorporation assay showed that the wheel control group, which was forced to run only during the active, dark phase, significantly reduced BrdU + cells compared with the control mice that were not forced to run. This result suggests that the wheel control condition may cause stress that can suppress cell proliferation. Moreover, 96 h of sleep deprivation suppressed cell proliferation by ∼50% compared with the control without inducing cell death (Fig. S1 ). NAS administration substantially protected sleep deprivation-suppressed hippocampal cell proliferation (Fig. 5 C and D) . These results demonstrate the protective function of NAS in promoting hippocampal cell proliferation during sleep deprivation.
To examine whether NAS provides its protective effect via the TrkB receptor activation, we performed an immunohistochemical staining of the dentate gyrus. The coimmunostaining of the samples with both nestin and p-706 TrkB antibodies is shown in Fig. 5E . The control dentate gyrus showed a large number of NPCs displayed TrkB phosphorylation. Wheel control animals exhibited a reduced number of nestin + p-TrkB, supporting the previous result that forced wheel exercise reduced neurogenesis. Further, sleep deprivation robustly suppressed TrkB phosphorylation in NPCs, which was partially reversed by NAS administration (Fig. 5F ). Similar results were obtained with p-TrkB 816/ nestin costaining (Fig. S2) . Moreover, coimmunostaining by both nestin and p-Akt antibodies showed a similar trend that NAS increased number of both nestin + and p-Akt + cells during sleep deprivation (Fig. 5 G and H) , suggesting the protective function of active Akt during sleep deprivation. Therefore, these results confirm our finding that NAS protects the sleep deprivationsuppressed NPC proliferation, which might be regulated by TrkB phosphorylation and its downstream effector, Akt, in neuronal progenitor cells. The data are presented as mean ± SEM from at least four animals each group (oneway ANOVA, *P < 0.05, **P < 0.01).
Discussion
Our study demonstrates that NAS but not melatonin is critical for promoting an early event of neurogenesis, NPC proliferation, in dentate gyrus in sleep-deprived mice, for which TrkB activation by NAS is indispensable. Interestingly, NAS triggers NPC proliferation in both the active and sleeping phases of mice. The nocturnal rodents sleep during the daytime and are active in the nighttime. The synthesis of NAS and melatonin is predominantly regulated by a circadian rhythm-sensitive, cAMP-dependent regulation of AANAT gene expression in the pineal gland (25, 26) . Pineal NAS and melatonin levels fluctuate with circadian rhythms, with low levels during the day and high levels at night (27) . Hence, the endogenous pineal gland-secreted NAS might not contribute to sleep-mediated neurogenesis in rodents. Nonetheless, it is possible that NAS can mediate neurogenesis in human during sleep at night. It is worth noting that administration of NAS significantly escalates NPC proliferation in C57BL/6J mice in the sleeping phase at 7:00 AM. NAS treatment at both 7:00 AM and 7:00 PM (sleep and active phases) further increases NPC proliferation. We made similar observations with C3H mice as well (Fig. 4) . Hence, exogenous NAS augments NPC proliferation in both the daytime and nighttime. We have shown that the TrkB activation pattern tightly correlates with NAS oscillation. TrkB activation displays a circadian rhythm in wild-type C3H/f( +/+ ) mice but not in AANAT-mutated C57BL/6J mice; TrkB activation is high at night in the dark and low during the day. Thus, NAS might directly activate TrkB receptor in the darkness (6) . Our data indeed support that chronic NAS administration exhibits a tendency to escalate TrkB activation in hippocampus, although the difference is not statistically significant. It is possible that TrkB activation in mature neurons and NPCs may have different responses to NAS, because we clearly show TrkB activation in NPCs after chronic NAS treatment ( Fig. 1 D and E) . Moreover, lower TrkB activation in mature neurons from whole hippocampal tissue samples may mask the activated TrkB levels in NPCs in immunoblotting and ELISA study (Fig. 2 B-D) . Nonetheless, we can see significant increase in p-TrkB in NPCs from immunofluorescence study (Fig. 1 D and E) but not from immunoblotting and ELISA study (Fig. 2 B-D) . By contrast, melatonin does not elevate TrkB activation. The significance of its inhibitory effect on TrkB phosphorylation remains unclear. Nevertheless, this finding supports the previous observations that NAS and melatonin have different physiological functions, and NAS acts as a potent neuroprotective agent through the neurotrophic receptor TrkB, whereas melatonin might exert its biological effects through melatonin receptors or as an antioxidant. Our results confirm the previous study that melatonin Fig. 4 . NAS induces hippocampal cell proliferation in active and sleeping phases. (A) Experimental design. Mice were exposed to normal light/dark cycle (LD) without treatment as a control group. NAS treatment groups were also exposed to the normal light/dark phase. To increase NAS in the early sleeping phase, mice were injected with NAS at 7:00 AM (zeitgeber time 0, ZT0). The mice were injected with NAS every 12 h at 7:00 AM (ZT0) and 7:00 PM (ZT12). The treatment lasted for 96 h. (B) Effect of NAS on hippocampal cells proliferation in C3H mice. Quantitative BrdU + cells showed that increasing of NAS in an early sleeping phase or in an active phase has no significant effect to induce hippocampal cell proliferation in wild-type AANAT, C3H/f( +/+ ) mice (n = 6 animals per group). (C) NAS elicits statistically significant hippocampal cell proliferation in C57BL/6J mice. Subchronic NAS treatment in the early sleeping phase (7:00 AM) and sleeping/active phases (7:00 AM/PM) for 96h enhanced hippocampal cell proliferation in AANAT mutant C57BL/6J mice (n = 4 each group). Data are expressed as mean ± SEM (*P < 0.05, one-way ANOVA). treatment did not increase the number of BrdU + cells even though we have extend the chronic time treatment to 3 wk (20) . However, melatonin may contribute to neuronal survival after NPC proliferation as shown by an increase in doublecortin + cells in a previous study (21) .
Endogenous NAS is synthesized with high concentrations in the nighttime. Here we show NAS can induce cell proliferation in both active and sleeping phases in rodents. It suggests that NAS alone is sufficient to provoke NPC proliferation regardless of the daytime or nighttime. Thus, the cell proliferation effect by NAS might be useful for fighting depression and other neuronal lossassociated stress conditions. We have used the same dose of melatonin 8 mg/kg in male C57BL/6J mice. However, we treated our mice for longer than 3 wk and observed no increase in BrdU + cells in the dentate gyrus, which is similar to the result in a 1-wk treatment as described in Ramirez-Rodriguez et al. (20) . The findings from our study and Ramirez-Rodriguez et al. (21) indicate that melatonin may not act as an inducer for NPC proliferation, whereas NAS does. Interestingly, the expression of BDNF mRNA and protein has been found to oscillate in a circadian fashion within suprachiasmatic nucleus (SCN) of the anterior hypothalamus (28) . Moreover, the expression of BDNF and TrkB display statistically significant circadian variation in rat hippocampus (29) . Conceivably, BDNF/TrkB system and NAS coordinately orchestrate a variety of neuronal activities in hippocampus with a style of circadian oscillation, e.g., hippocampal neurogenesis and antidepressant.
Integration of new neurons into neuronal circuits may support hippocampal-dependent function such as learning and memory storage (30) (31) (32) . Many of these modulators of neurogenesis are also known to affect sleep. For example, exercise enhances sleep in rats, whereas aging (33) and chronic stress (34) reduce sleep. Likewise, the intracerebroventricular infusion of EGF, IGF-I, and BDNF enhances sleep (35, 36) . These facts suggest that sleep may contribute to hippocampal functions by promoting neurogenesis. However, to date it is not completely clear whether sleep or sleep loss has effects on the different stages of neurogenesis including cell proliferation. Sleep deprivation by 96 h reduces cell proliferation and neurogenesis in the dentate gyrus of the hippocampus in adult rats (37) . Here we show that sleep deprivation significantly diminished NPC proliferation in C57BL/ 6J mice, whereas the similar experiment paradigm failed to trigger a similar effect in C3H mice (Fig. 5 B and D) . Interestingly, administration of NAS in the sleep-deprived mice significantly increased NPC proliferation in C57BL6 mice but not C3H mice. Presumably, the endogenous NAS in C3H mice buffered the detrimental effect of sleep deprivation. Because C57BL/6J mice lack functional AANAT and sufficient NAS, exogenous NAS administration might substantially up-regulate NPC proliferation during sleep deprivation in this animal. 
